nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0916	0.456	CbGbCtD
Tizanidine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0732	0.365	CbGbCtD
Tizanidine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0358	0.179	CbGbCtD
Tizanidine—NISCH—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00826	0.592	CbGdCrCtD
Tizanidine—NISCH—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00568	0.408	CbGdCrCtD
Tizanidine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000365	0.000465	CcSEcCtD
Tizanidine—Infection—Etoposide—peripheral nervous system neoplasm	0.000364	0.000464	CcSEcCtD
Tizanidine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.000463	CcSEcCtD
Tizanidine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000364	0.000463	CcSEcCtD
Tizanidine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000362	0.00046	CcSEcCtD
Tizanidine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000362	0.00046	CcSEcCtD
Tizanidine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000362	0.00046	CcSEcCtD
Tizanidine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00036	0.000458	CcSEcCtD
Tizanidine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000359	0.000457	CcSEcCtD
Tizanidine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000358	0.000456	CcSEcCtD
Tizanidine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000358	0.000456	CcSEcCtD
Tizanidine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000358	0.000456	CcSEcCtD
Tizanidine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000455	CcSEcCtD
Tizanidine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000357	0.000455	CcSEcCtD
Tizanidine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000356	0.000454	CcSEcCtD
Tizanidine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000452	CcSEcCtD
Tizanidine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000355	0.000452	CcSEcCtD
Tizanidine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.00045	CcSEcCtD
Tizanidine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000449	CcSEcCtD
Tizanidine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000448	CcSEcCtD
Tizanidine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000443	CcSEcCtD
Tizanidine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000347	0.000442	CcSEcCtD
Tizanidine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.000441	CcSEcCtD
Tizanidine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000343	0.000436	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000435	CcSEcCtD
Tizanidine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000435	CcSEcCtD
Tizanidine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.000429	CcSEcCtD
Tizanidine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000426	CcSEcCtD
Tizanidine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000426	CcSEcCtD
Tizanidine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000426	CcSEcCtD
Tizanidine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000425	CcSEcCtD
Tizanidine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000334	0.000425	CcSEcCtD
Tizanidine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.000423	CcSEcCtD
Tizanidine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00033	0.00042	CcSEcCtD
Tizanidine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000329	0.000419	CcSEcCtD
Tizanidine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000417	CcSEcCtD
Tizanidine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000327	0.000416	CcSEcCtD
Tizanidine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000415	CcSEcCtD
Tizanidine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000326	0.000415	CcSEcCtD
Tizanidine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000415	CcSEcCtD
Tizanidine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000325	0.000414	CcSEcCtD
Tizanidine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000413	CcSEcCtD
Tizanidine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000411	CcSEcCtD
Tizanidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.00041	CcSEcCtD
Tizanidine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.00041	CcSEcCtD
Tizanidine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000322	0.000409	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000407	CcSEcCtD
Tizanidine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00032	0.000407	CcSEcCtD
Tizanidine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000404	CcSEcCtD
Tizanidine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000317	0.000403	CcSEcCtD
Tizanidine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000316	0.000403	CcSEcCtD
Tizanidine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000402	CcSEcCtD
Tizanidine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000314	0.0004	CcSEcCtD
Tizanidine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000314	0.000399	CcSEcCtD
Tizanidine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000399	CcSEcCtD
Tizanidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000396	CcSEcCtD
Tizanidine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00031	0.000395	CcSEcCtD
Tizanidine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000394	CcSEcCtD
Tizanidine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000394	CcSEcCtD
Tizanidine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000391	CcSEcCtD
Tizanidine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000388	CcSEcCtD
Tizanidine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000385	CcSEcCtD
Tizanidine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000385	CcSEcCtD
Tizanidine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000302	0.000385	CcSEcCtD
Tizanidine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000384	CcSEcCtD
Tizanidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000301	0.000383	CcSEcCtD
Tizanidine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000383	CcSEcCtD
Tizanidine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000382	CcSEcCtD
Tizanidine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.0003	0.000382	CcSEcCtD
Tizanidine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000299	0.000381	CcSEcCtD
Tizanidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00038	CcSEcCtD
Tizanidine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00038	CcSEcCtD
Tizanidine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000296	0.000377	CcSEcCtD
Tizanidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000296	0.000377	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000377	CcSEcCtD
Tizanidine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000295	0.000376	CcSEcCtD
Tizanidine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000375	CcSEcCtD
Tizanidine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000373	CcSEcCtD
Tizanidine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000372	CcSEcCtD
Tizanidine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000291	0.000371	CcSEcCtD
Tizanidine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000291	0.00037	CcSEcCtD
Tizanidine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.00037	CcSEcCtD
Tizanidine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000369	CcSEcCtD
Tizanidine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00029	0.000369	CcSEcCtD
Tizanidine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00029	0.000369	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000369	CcSEcCtD
Tizanidine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000369	CcSEcCtD
Tizanidine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000369	CcSEcCtD
Tizanidine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000288	0.000367	CcSEcCtD
Tizanidine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000366	CcSEcCtD
Tizanidine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000366	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000364	CcSEcCtD
Tizanidine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000364	CcSEcCtD
Tizanidine—Rash—Vincristine—peripheral nervous system neoplasm	0.000286	0.000364	CcSEcCtD
Tizanidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000285	0.000363	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000362	CcSEcCtD
Tizanidine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000362	CcSEcCtD
Tizanidine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000361	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000359	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000356	CcSEcCtD
Tizanidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.000355	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000354	CcSEcCtD
Tizanidine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000274	0.000349	CcSEcCtD
Tizanidine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000348	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000347	CcSEcCtD
Tizanidine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00027	0.000344	CcSEcCtD
Tizanidine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000344	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000343	CcSEcCtD
Tizanidine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000269	0.000342	CcSEcCtD
Tizanidine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000342	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000342	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000341	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000341	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000338	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000337	CcSEcCtD
Tizanidine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000263	0.000335	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000335	CcSEcCtD
Tizanidine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000334	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000334	CcSEcCtD
Tizanidine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000333	CcSEcCtD
Tizanidine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000332	CcSEcCtD
Tizanidine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00026	0.00033	CcSEcCtD
Tizanidine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000329	CcSEcCtD
Tizanidine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000326	CcSEcCtD
Tizanidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000255	0.000324	CcSEcCtD
Tizanidine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000323	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000322	CcSEcCtD
Tizanidine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000252	0.000321	CcSEcCtD
Tizanidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000252	0.000321	CcSEcCtD
Tizanidine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000251	0.00032	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000318	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000316	CcSEcCtD
Tizanidine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000316	CcSEcCtD
Tizanidine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000315	CcSEcCtD
Tizanidine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000312	CcSEcCtD
Tizanidine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00031	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000309	CcSEcCtD
Tizanidine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000243	0.000309	CcSEcCtD
Tizanidine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000308	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000308	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000307	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000305	CcSEcCtD
Tizanidine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000238	0.000303	CcSEcCtD
Tizanidine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000302	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000301	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000299	CcSEcCtD
Tizanidine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000298	CcSEcCtD
Tizanidine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000233	0.000297	CcSEcCtD
Tizanidine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000297	CcSEcCtD
Tizanidine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000295	CcSEcCtD
Tizanidine—Rash—Etoposide—peripheral nervous system neoplasm	0.000231	0.000295	CcSEcCtD
Tizanidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000231	0.000294	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000292	CcSEcCtD
Tizanidine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000291	CcSEcCtD
Tizanidine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000289	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000288	CcSEcCtD
Tizanidine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000288	CcSEcCtD
Tizanidine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000288	CcSEcCtD
Tizanidine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000287	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000287	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000285	CcSEcCtD
Tizanidine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000282	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00028	CcSEcCtD
Tizanidine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000278	CcSEcCtD
Tizanidine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000218	0.000277	CcSEcCtD
Tizanidine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000277	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000275	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000274	CcSEcCtD
Tizanidine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000273	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000273	CcSEcCtD
Tizanidine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000272	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000271	CcSEcCtD
Tizanidine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000212	0.00027	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000268	CcSEcCtD
Tizanidine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000267	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000267	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000266	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000266	CcSEcCtD
Tizanidine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000264	CcSEcCtD
Tizanidine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000262	CcSEcCtD
Tizanidine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000262	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000261	CcSEcCtD
Tizanidine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000204	0.00026	CcSEcCtD
Tizanidine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000258	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000257	CcSEcCtD
Tizanidine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000257	CcSEcCtD
Tizanidine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000256	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000256	CcSEcCtD
Tizanidine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000256	CcSEcCtD
Tizanidine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000254	CcSEcCtD
Tizanidine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000253	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000253	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000252	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000251	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00025	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000247	CcSEcCtD
Tizanidine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000245	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000244	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000242	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000242	CcSEcCtD
Tizanidine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000241	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000239	CcSEcCtD
Tizanidine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000238	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000238	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000237	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000236	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000235	CcSEcCtD
Tizanidine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000235	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000234	CcSEcCtD
Tizanidine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000233	CcSEcCtD
Tizanidine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000233	CcSEcCtD
Tizanidine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.00023	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000226	CcSEcCtD
Tizanidine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000226	CcSEcCtD
Tizanidine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000224	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000221	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000218	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000216	CcSEcCtD
Tizanidine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000216	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000215	CcSEcCtD
Tizanidine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000214	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000213	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000209	CcSEcCtD
Tizanidine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000208	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000207	CcSEcCtD
Tizanidine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000207	CcSEcCtD
Tizanidine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000207	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.0002	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000198	CcSEcCtD
Tizanidine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000193	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000192	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000192	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000192	CcSEcCtD
Tizanidine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000188	CcSEcCtD
Tizanidine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000185	CcSEcCtD
Tizanidine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000179	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000178	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000174	CcSEcCtD
Tizanidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000173	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000171	CcSEcCtD
Tizanidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000166	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000166	CcSEcCtD
Tizanidine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000165	CcSEcCtD
Tizanidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000165	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00016	CcSEcCtD
Tizanidine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000156	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000154	CcSEcCtD
Tizanidine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000153	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000153	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000144	CcSEcCtD
